# OpiCapone Effect on Motor Fluctuations and pAiN

> **NCT04986982** · PHASE4 · COMPLETED · sponsor: **Bial - Portela C S.A.** · enrollment: 144 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **DRUG:** Opicapone 50 mg
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04986982
- **Lead sponsor:** Bial - Portela C S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-25
- **Primary completion:** 2024-02-16
- **Final completion:** 2024-02-16
- **Target enrollment:** 144 (ACTUAL)
- **Last updated:** 2025-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04986982

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04986982, "OpiCapone Effect on Motor Fluctuations and pAiN". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04986982. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*